vs
英美资源集团（AMSC）与MEDIFAST INC（MED）财务数据对比。点击上方公司名可切换其他公司
MEDIFAST INC的季度营收约是英美资源集团的1.0倍（$75.1M vs $74.5M），英美资源集团同比增速更快（21.4% vs -36.9%），英美资源集团自由现金流更多（$2.4M vs $-6.6M），过去两年英美资源集团的营收复合增速更高（33.2% vs -34.4%）
英美资源集团是一家总部位于英国伦敦的跨国矿业企业，是全球最大的铂金生产商，产量约占全球总产出的40%，同时也是钻石、铜、镍、铁矿石、多卤石、炼焦煤的主要供应商，业务布局覆盖非洲、亚洲、大洋洲、欧洲、南北美洲多个地区。
迈德福斯特是一家总部位于美国马里兰州巴尔的摩的营养减重企业，该公司研发、分销并销售减重及健康相关产品，销售渠道涵盖官方网站、多层次营销、电话销售以及品牌加盟减重诊所。
AMSC vs MED — 直观对比
营收规模更大
MED
是对方的1.0倍
$74.5M
营收增速更快
AMSC
高出58.3%
-36.9%
自由现金流更多
AMSC
多$9.0M
$-6.6M
两年增速更快
AMSC
近两年复合增速
-34.4%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $74.5M | $75.1M |
| 净利润 | $117.8M | — |
| 毛利率 | 30.7% | 69.4% |
| 营业利润率 | 4.5% | -10.4% |
| 净利率 | 158.1% | — |
| 营收同比 | 21.4% | -36.9% |
| 净利润同比 | 4679.1% | — |
| 每股收益（稀释后） | $2.62 | $-1.64 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMSCMED
| Q4 25 | $74.5M | $75.1M | ||
| Q3 25 | $65.9M | $89.4M | ||
| Q2 25 | $72.4M | $105.6M | ||
| Q1 25 | $66.7M | $115.7M | ||
| Q4 24 | $61.4M | $119.0M | ||
| Q3 24 | $54.5M | $140.2M | ||
| Q2 24 | $40.3M | $168.6M | ||
| Q1 24 | $42.0M | $174.7M |
净利润AMSCMED
| Q4 25 | $117.8M | — | ||
| Q3 25 | $4.8M | $-2.3M | ||
| Q2 25 | $6.7M | $2.5M | ||
| Q1 25 | $1.2M | $-772.0K | ||
| Q4 24 | $2.5M | — | ||
| Q3 24 | $4.9M | $1.1M | ||
| Q2 24 | $-2.5M | $-8.2M | ||
| Q1 24 | $-1.6M | $8.3M |
毛利率AMSCMED
| Q4 25 | 30.7% | 69.4% | ||
| Q3 25 | 31.0% | 69.5% | ||
| Q2 25 | 33.8% | 72.6% | ||
| Q1 25 | 26.5% | 72.8% | ||
| Q4 24 | 26.6% | 74.1% | ||
| Q3 24 | 28.7% | 75.4% | ||
| Q2 24 | 30.3% | 73.2% | ||
| Q1 24 | 24.8% | 72.8% |
营业利润率AMSCMED
| Q4 25 | 4.5% | -10.4% | ||
| Q3 25 | 4.5% | -4.6% | ||
| Q2 25 | 7.8% | -1.0% | ||
| Q1 25 | 2.5% | -1.1% | ||
| Q4 24 | 2.1% | 0.6% | ||
| Q3 24 | -1.4% | 1.5% | ||
| Q2 24 | -8.2% | -4.7% | ||
| Q1 24 | -5.3% | 4.5% |
净利率AMSCMED
| Q4 25 | 158.1% | — | ||
| Q3 25 | 7.2% | -2.5% | ||
| Q2 25 | 9.3% | 2.3% | ||
| Q1 25 | 1.8% | -0.7% | ||
| Q4 24 | 4.0% | — | ||
| Q3 24 | 9.0% | 0.8% | ||
| Q2 24 | -6.3% | -4.8% | ||
| Q1 24 | -3.8% | 4.8% |
每股收益（稀释后）AMSCMED
| Q4 25 | $2.62 | $-1.64 | ||
| Q3 25 | $0.11 | $-0.21 | ||
| Q2 25 | $0.17 | $0.22 | ||
| Q1 25 | $0.04 | $-0.07 | ||
| Q4 24 | $0.06 | $0.08 | ||
| Q3 24 | $0.13 | $0.10 | ||
| Q2 24 | $-0.07 | $-0.75 | ||
| Q1 24 | $-0.03 | $0.76 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $141.1M | $167.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $536.8M | $198.9M |
| 总资产 | $719.5M | $248.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AMSCMED
| Q4 25 | $141.1M | $167.3M | ||
| Q3 25 | $212.9M | $173.5M | ||
| Q2 25 | $207.9M | $162.7M | ||
| Q1 25 | $79.5M | $164.6M | ||
| Q4 24 | $75.2M | $162.3M | ||
| Q3 24 | $72.1M | $170.0M | ||
| Q2 24 | $93.5M | $163.5M | ||
| Q1 24 | $90.5M | $156.4M |
股东权益AMSCMED
| Q4 25 | $536.8M | $198.9M | ||
| Q3 25 | $342.2M | $214.7M | ||
| Q2 25 | $333.1M | $216.0M | ||
| Q1 25 | $197.1M | $211.0M | ||
| Q4 24 | $192.7M | $210.1M | ||
| Q3 24 | $187.0M | $207.3M | ||
| Q2 24 | $143.3M | $205.3M | ||
| Q1 24 | $144.6M | $211.0M |
总资产AMSCMED
| Q4 25 | $719.5M | $248.0M | ||
| Q3 25 | $445.6M | $268.2M | ||
| Q2 25 | $452.8M | $269.3M | ||
| Q1 25 | $310.5M | $280.0M | ||
| Q4 24 | $310.3M | $284.2M | ||
| Q3 24 | $298.4M | $291.2M | ||
| Q2 24 | $240.1M | $293.5M | ||
| Q1 24 | $232.8M | $302.8M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.2M | $-5.3M |
| 自由现金流经营现金流 - 资本支出 | $2.4M | $-6.6M |
| 自由现金流率自由现金流/营收 | 3.2% | -8.8% |
| 资本支出强度资本支出/营收 | 1.2% | 1.8% |
| 现金转化率经营现金流/净利润 | 0.03× | — |
| 过去12个月自由现金流最近4个季度 | $16.0M | $1.2M |
8季度趋势，按日历期对齐
经营现金流AMSCMED
| Q4 25 | $3.2M | $-5.3M | ||
| Q3 25 | $6.5M | $12.1M | ||
| Q2 25 | $4.1M | $-3.4M | ||
| Q1 25 | $6.3M | $3.4M | ||
| Q4 24 | $5.9M | $-4.9M | ||
| Q3 24 | $12.7M | $9.1M | ||
| Q2 24 | $3.4M | $13.1M | ||
| Q1 24 | $2.2M | $7.3M |
自由现金流AMSCMED
| Q4 25 | $2.4M | $-6.6M | ||
| Q3 25 | $5.1M | $10.8M | ||
| Q2 25 | $3.3M | $-4.8M | ||
| Q1 25 | $5.3M | $1.9M | ||
| Q4 24 | $5.3M | $-7.2M | ||
| Q3 24 | $12.1M | $7.7M | ||
| Q2 24 | $3.1M | $11.1M | ||
| Q1 24 | $1.9M | $5.4M |
自由现金流率AMSCMED
| Q4 25 | 3.2% | -8.8% | ||
| Q3 25 | 7.7% | 12.0% | ||
| Q2 25 | 4.6% | -4.5% | ||
| Q1 25 | 7.9% | 1.6% | ||
| Q4 24 | 8.7% | -6.1% | ||
| Q3 24 | 22.3% | 5.5% | ||
| Q2 24 | 7.8% | 6.6% | ||
| Q1 24 | 4.6% | 3.1% |
资本支出强度AMSCMED
| Q4 25 | 1.2% | 1.8% | ||
| Q3 25 | 2.1% | 1.5% | ||
| Q2 25 | 1.1% | 1.3% | ||
| Q1 25 | 1.6% | 1.3% | ||
| Q4 24 | 0.9% | 1.9% | ||
| Q3 24 | 1.1% | 1.0% | ||
| Q2 24 | 0.7% | 1.1% | ||
| Q1 24 | 0.7% | 1.1% |
现金转化率AMSCMED
| Q4 25 | 0.03× | — | ||
| Q3 25 | 1.37× | — | ||
| Q2 25 | 0.61× | -1.36× | ||
| Q1 25 | 5.22× | — | ||
| Q4 24 | 2.38× | — | ||
| Q3 24 | 2.60× | 8.04× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.88× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMSC
| Equipment And Systems | $56.0M | 75% |
| Megatran | $14.1M | 19% |
| Comtrafo Industria De Transformadores Eletricos SA | $4.6M | 6% |
MED
暂无分部数据
